Propanc Biopharma, Inc. Common Stock (PPCB) — Long-term Investment Intensity
Propanc Biopharma, Inc. Common Stock (PPCB) has a Long-term Investment Intensity of 0.8% as of March 2019. Long-term investments of $2.13K represent 0.8% of total assets of $259.92K. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Propanc Biopharma, Inc. Common Stock reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Annual Long-term Investment Intensity for Propanc Biopharma, Inc. Common Stock (None–None)
The table below presents the year-by-year Long-term Investment Intensity for Propanc Biopharma, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Propanc Biopharma, Inc. Common Stock.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|